Clinical Trial Update: Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, and pharmacodynamic effects of ISIS CRP Rx in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ISIS CRP Rx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED